Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biocruces Bizkaia (85)

2023

  1. A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer

    Actas Urologicas Espanolas, Vol. 47, Núm. 2, pp. 111-126

  2. Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors’ reply

    Actas Urologicas Espanolas

  3. Activity recovery for differently shaped objects in quantitative SPECT

    Physics in Medicine and Biology, Vol. 68, Núm. 12

  4. An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine

    European Journal of Nuclear Medicine and Molecular Imaging

  5. Correction to: EANM enabling guide: how to improve the accessibility of clinical dosimetry (European Journal of Nuclear Medicine and Molecular Imaging, (2023), 50, 7, (1861-1868), 10.1007/s00259-023-06226-z)

    European Journal of Nuclear Medicine and Molecular Imaging

  6. EANM enabling guide: how to improve the accessibility of clinical dosimetry

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 7, pp. 1861-1868

  7. EANM practice guideline for quantitative SPECT-CT

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 4, pp. 980-995

  8. EFOMP policy statement NO. 19: Dosimetry in nuclear medicine therapy – Molecular radiotherapy

    Physica Medica, Vol. 116

  9. ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy

    Clinical and Translational Radiation Oncology, Vol. 43

  10. ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer

    Clinical and Translational Radiation Oncology, Vol. 41

  11. Fast cardiac magnetic resonance protocol. Feasibility of accelerated compressed sensing cine sequences in clinical practice

    Radiologia

  12. Individualisation of radiation protection recommendations for patients treated with [177Lu]Lu-DOTA-TATE

    EJNMMI Physics, Vol. 10, Núm. 1